Persistent Efficacy of Dextromethorphan (DM)/Quinidine (Q) for Pseudobulbar Affect (PBA): Results from a 12-Week, Open-Label Extension (OLE) Study

被引：0
|
作者：
Pioro, Erik
Brooks, Benjamin
Cummings, Jeffrey
Schiffer, Randolph
Wynn, Daniel
Hepner, Adrian
Kaye, Randall
机构：
来源：
NEUROLOGY | 2010年 / 75卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：380 / 380
页数：1
相关论文
共 50 条
  • [21] PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury (vol 16, 89, 2016)
    Hammond, Flora M.
    Alexander, David N.
    Cutler, Andrew J.
    D'Amico, Stephen
    Doody, Rachelle S.
    Sauve, William
    Zorowitz, Richard D.
    Davis, Charles S.
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Formella, Andrea E.
    Siffert, Joao
    BMC NEUROLOGY, 2016, 16
  • [22] Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study
    Chen, Jun
    Muzina, David J.
    Kemp, David E.
    Conroy, Carla
    Chan, Philip
    Serrano, Mary Beth
    Ganocy, Stephen J.
    Fang, Yiru
    Calabrese, Joseph R.
    Gao, Keming
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (08) : 588 - 595
  • [23] Efficacy and tolerability of carbamazepine for the treatment of painful diabetic neuropathy in adults: a 12-week, open-label, multicenter study
    Saeed, Tariq
    Nasrullah, Muhammad
    Ghafoor, Adnan
    Shahid, Riaz
    Islam, Nadeem
    Khattak, Mohammad Usman
    Maheshwary, Neeta
    Siddiqi, Ahson
    Khan, Muhammad Athar
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2014, 7 : 339 - 343
  • [24] A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma
    Emeryk, Andrzej
    Klink, Rabih
    McIver, Tammy
    Dalvi, Prashant
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (04) : 324 - 337
  • [25] PRISM II: Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®) for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Combined Results of a Multicenter Open-Label Study
    Siffert, Joao
    Hammond, Flora
    Alexander, David
    Cutler, Andrew
    D'Amico, Stephen
    Doody, Rachelle
    Sauve, William
    Zorowitz, Richard
    Davis, Charles
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Formella, Andrea
    NEUROLOGY, 2016, 86
  • [26] PRISM II: Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA) for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Combined Results of a Multicenter Open-label Study
    Hammond, Flora
    Siffert, Joao
    Alexander, David
    Cutler, Andrew J.
    D'Amico, Stephen
    Doody, Rachelle
    Formella, Andrea
    Ledon, Fred
    Sauve, William
    Shin, Paul
    Yonan, Charles
    Zorowitz, Richard
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S365 - S366
  • [27] Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL) study
    Gaydukova, I. Z.
    Rebrov, A. P.
    Poddubnyi, D. A.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (05): : 47 - 52
  • [28] Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: Results of a 12-week, open label study
    Yoshitomi, Y
    Ishii, T
    Kaneki, M
    Tsujibayashi, T
    Sakurai, S
    Nagakura, C
    Miyauchi, A
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2006, 13 (02) : 108 - 113
  • [29] EFFICACY AND SAFETY OF METHYLPREDNISOLONE ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY (METALL)
    Gaydukova, I.
    Rebrov, A.
    Poddubnyy, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1024 - 1025
  • [30] Switching from other second generation antipsychotics to zotepine in schizophrenic patients: an 12-week open-label study
    Chen, J. Y.
    Chen, T. T.
    Lin, C. C.
    Bai, Y. M.
    Wu, B. J.
    Hung, C. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S416 - S417
12345